Scytonemin, a lipid-soluble indole-alkaloid pigment unique to cyanobacteria, is a bioactive small molecule with UV-shielding, antioxidant, and anti-inflammatory activities. Nostoc flagelliforme represents a promising strain for scytonemin biosynthesis, yet engineering to boost its yield remains challenging. Two genes encoding a histidine kinase (COO91_00772) and a response regulator (COO91_00771, ScyR) putatively constitute a two-component regulatory system governing the UV-induced biosynthesis of scytonemin. Here, we employed CRISPR/Cpf1 technology to achieve the insertion of an additional ScyR expression cassette into the N. flagelliforme genome and evaluated its effect on scytonemin yield. The engineered strain was designated Nf-psbA-ScyR, in which the ScyR gene was expressed under the PpsbA promoter. This strain exhibited a markedly enhanced accumulation of scytonemin, reaching 4.6 mg g−1 dry weight under UV-B radiation after 15-day cultivation with exogenous tryptophan supplementation, representing a 1.9-fold increase compared with the MAAs-deficient (Nf-MAAs-D) strain. Upon transition from indoor UV-B exposure to outdoor solar radiation, scytonemin production further increased to 5.4 mg g−1 dry weight. These findings indicate that the ScyR regulator can highly promote scytonemin biosynthesis under UV induction, providing an engineering strategy for the exploitation of N. flagelliforme.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: